OCSpring24_04

Advances in HER2-Mutant NSCLC: Optimizing Outcomes in Rural and Underserved Communities

Date

April 13, 2024

Explore related products in the following collection:

Oncology Congress - Apr 2024

Speakers

Rebecca S. Heist, MD, MPH

Lee Albright and Nile Albright MD Endowed Chair, Clinical Cancer Research, Massachusetts General Hospital Cancer Center

Chris Prakash, MD

Medical Director, Texas Oncology - Paris

Related Products

Thumbnail for Break #1

Thumbnail for PARP Inhibitors in Prostate Cancer: Practical Application of Recent Advances to Ensure Equitable Care in Rural and Underserved Populations

PARP Inhibitors in Prostate Cancer: Practical Application of Recent Advances to Ensure Equitable Care in Rural and Underserved Populations

Thumbnail for Improving Equity in Hepatocellular Carcinoma Care: Integrating Evolving Treatment Approaches in Rural and Underserved Communities

Improving Equity in Hepatocellular Carcinoma Care: Integrating Evolving Treatment Approaches in Rural and Underserved Communities

Thumbnail for TROP2-Targeted Antibody-Drug Conjugates in NSCLC: An Update for Oncologists Who Serve Patients in Rural and Underserved Communities

TROP2-Targeted Antibody-Drug Conjugates in NSCLC: An Update for Oncologists Who Serve Patients in Rural and Underserved Communities